Department of Child and Adolescent Psychiatry, LVR-Klinikum Essen, University of Duisburg-Essen; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; German Center for Mental Health (DZPG), Partner Site Berlin.
Dtsch Arztebl Int. 2024 Mar 8;121(5):164-174. doi: 10.3238/arztebl.m2023.0248.
Anorexia nervosa (AN) is a serious disease with a lifetime prevalence of up to 3.6% in women and 0.3% in men. Abnormally low weight and the associated starvation partly account for its somatic and mental manifestations.
This review is based on publications retrieved by a selective search concerning AN in childhood and adolescence.
The peak age of onset of AN is 15.5 years. The frequency of inpatient treatment for AN rose by 40% during the COVID pandemic, indicating the importance of environmental factors; the heritability of AN is estimated at 0.5. The ICD-11 sets the threshold for AN-associated underweight at the fifth percentile for age of the body mass index, as long as the remaining diagnostic criteria are met. The main goal of the multiprofessional treatment of AN is the return to normal body weight, which is a central prerequisite for regaining somatic and mental health. The mean duration of AN is 3.4 years, and approximately twothirds of patients recover from the disease over the long term.
Marked weight loss in childhood and adolescence can trigger AN in the presence of a predisposition to this disease. Patients and their families should receive psychoeducation regarding the symptoms of starvation and their overlap with those of AN. Important objectives are to shorten the duration of the illness, minimize mortality and the risk of chronic illness, and to identify pharmacological approaches to treatment.
神经性厌食症(AN)是一种严重的疾病,女性终生患病率高达 3.6%,男性为 0.3%。异常低的体重和由此导致的饥饿部分解释了其躯体和精神表现。
这篇综述基于有关儿童和青少年时期 AN 的选择性搜索出版物。
AN 的发病高峰年龄为 15.5 岁。在 COVID 大流行期间,AN 的住院治疗频率上升了 40%,表明环境因素的重要性;AN 的遗传率估计为 0.5。ICD-11 将与 AN 相关的体重不足的阈值设定为身体质量指数年龄的第 5 百分位,只要满足其余的诊断标准。AN 的多专业治疗的主要目标是恢复正常体重,这是恢复躯体和心理健康的核心前提。AN 的平均持续时间为 3.4 年,大约三分之二的患者在长期内从疾病中康复。
儿童和青少年时期明显的体重减轻可能会在存在这种疾病倾向的情况下引发 AN。患者及其家属应接受关于饥饿症状及其与 AN 重叠的心理教育。重要目标是缩短疾病持续时间、降低死亡率和慢性病风险,并确定治疗的药物方法。